Literature DB >> 23047811

Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Jeremy Rosenblum1, Juan Lin, Mimi Kim, Adam S Levy.   

Abstract

BACKGROUND: Febrile neutropenia is a common reason for the hospitalization of pediatric oncology patients. The initiation of antibiotics and the overall decline in rates of bacteremia, would predict a low yield of detection of bacteremia in repeated blood cultures. Despite little evidence supporting the utility of serial cultures, repeat culturing with fever persists. PROCEDURE: To determine the rate of follow-up blood culture growth when the initial blood culture showed no bacterial growth and patient risk factors for this occurrence, we reviewed the records of oncology patients admitted to the Children's Hospital at Montefiore Pediatric Hematology/Oncology service for febrile neutropenia from 2004 to 2009.
RESULTS: We identified 457 febrile neutropenia episodes in 137 patients. The initial blood culture was positive in 84 episodes (18.4%). In 220 episodes comprising 105 patients, the initial blood culture was negative and a subsequent culture was obtained. In 24 episodes (10.9%), bacterial growth was detected in the repeat culture. Risk factors included a previous history of bacteremia and hospitalization for more than 48 hours prior to onset of fever.
CONCLUSIONS: In patients with febrile neutropenia, bacteremia is detected nearly twice as frequently in initial blood cultures than in repeat blood cultures obtained when the initial blood culture is negative. Despite an initial negative blood culture, bacteremia can be detected in more than 10% of episodes when a repeat blood culture is obtained. The risk more than doubles for patients with a previous history of bacteremia or hospitalized for more than 48 hours prior to the onset of fever.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23047811      PMCID: PMC3992245          DOI: 10.1002/pbc.24358

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  23 in total

1.  Optimal testing parameters for blood cultures.

Authors:  F R Cockerill; J W Wilson; E A Vetter; K M Goodman; C A Torgerson; W S Harmsen; C D Schleck; D M Ilstrup; J A Washington; W R Wilson
Journal:  Clin Infect Dis       Date:  2004-05-25       Impact factor: 9.079

2.  Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky; A S Levine; A B Deisseroth; D L Glaubiger; J D Maclowry; I T Magrath; D G Poplack; R M Simon
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

3.  Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.

Authors:  E P Baorto; V M Aquino; C A Mullen; G R Buchanan; M R DeBaun
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

4.  Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.

Authors:  M E Santolaya; A M Alvarez; A Becker; J Cofré; N Enríquez; M O'Ryan; E Payá; J Pilorget; C Salgado; J Tordecilla; M Varas; M Villarroel; T Viviani; M Zubieta
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

5.  Blood culturing practices in a trauma intensive care unit: does concurrent antibiotic use make a difference?

Authors:  Carol R Schermer; Damion P Sanchez; Clifford R Qualls; Gerald B Demarest; Roxie M Albrecht; Donald E Fry
Journal:  J Trauma       Date:  2002-03

6.  Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.

Authors:  J S Serody; M M Berrey; K Albritton; S M O'Brien; E P Capel; S H Bigelow; D J Weber; J M Wiley; M J Schell; P H Gilligan; T C Shea
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

7.  "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia.

Authors:  R J Klaassen; T R Goodman; B Pham; J J Doyle
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

8.  Detection of bloodstream infections in adults: how many blood cultures are needed?

Authors:  Andrew Lee; Stanley Mirrett; L Barth Reller; Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

9.  Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.

Authors:  María E Santolaya; Ana M Alvarez; Carmen L Avilés; Ana Becker; José Cofré; Miguel A Cumsille; Miguel L O'Ryan; Ernesto Payá; Carmen Salgado; Pamela Silva; Juan Tordecilla; Mónica Varas; Milena Villarroel; Tamara Viviani; Marcela Zubieta
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

10.  Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume.

Authors:  Aditya H Gaur; Mary Anne Giannini; Patricia M Flynn; Jan W Boudreaux; Mark A Mestemacher; Jerry L Shenep; Randall T Hayden
Journal:  Pediatr Infect Dis J       Date:  2003-06       Impact factor: 2.129

View more
  8 in total

1.  Repeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implications.

Authors:  Rachel L Wattier; Christopher C Dvorak; Andrew D Auerbach; Peggy S Weintrub
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

2.  Enterococcus spp. and S. aureus colonization in neutropenic febrile children with cancer.

Authors:  Julia R Spinardi; Rodrigo Berea; Patricia A Orioli; Marina M Gabriele; Alessandra Navarini; Marina T Marques; Milton N Neto; Marcelo J Mimica
Journal:  Germs       Date:  2017-06-01

3.  Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience.

Authors:  Nihal Özdemir; Gülen Tüysüz; Nigar Çelik; Leman Yantri; Ethem Erginöz; Hilmi Apak; Alp Özkan; İnci Yıldız; Tiraje Celkan
Journal:  Turk Pediatri Ars       Date:  2016-06-01

4.  Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.

Authors:  Naima A Al-Mulla; Saad J Taj-Aldeen; Sittana El Shafie; Mohammed Janahi; Abdullah A Al-Nasser; Prem Chandra
Journal:  Infect Drug Resist       Date:  2014-11-06       Impact factor: 4.003

5.  Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland.

Authors:  Max Scheler; Thomas Lehrnbecher; Andreas H Groll; Ruth Volland; Hans-Jürgen Laws; Roland A Ammann; Philipp Agyeman; Andishe Attarbaschi; Margaux Lux; Arne Simon
Journal:  Infection       Date:  2020-06-10       Impact factor: 3.553

Review 6.  Challenges in the Etiology and Diagnosis of Acute Febrile Illness in Children in Low- and Middle-Income Countries.

Authors:  Pui-Ying Iroh Tam; Stephen K Obaro; Gregory Storch
Journal:  J Pediatric Infect Dis Soc       Date:  2016-04-07       Impact factor: 3.164

7.  Prospective evaluation of SeptiFast Multiplex PCR in children with systemic inflammatory response syndrome under antibiotic treatment.

Authors:  Franziska Gies; Eva Tschiedel; Ursula Felderhoff-Müser; Peter-Michael Rath; Joerg Steinmann; Christian Dohna-Schwake
Journal:  BMC Infect Dis       Date:  2016-08-08       Impact factor: 3.090

8.  Timing of Blood Cultures in the Setting of Febrile Neutropenia: An Australian Institutional Experience

Authors:  Samuel Wang
Journal:  Turk J Haematol       Date:  2020-10-15       Impact factor: 1.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.